STING1 and nasopharyngeal carcinoma: As shown in Fig. 2i, during the course of chemotherapy and/or radiotherapy, STING levels in serum of NPC patients with objective response were higher than those in the serum of patients with stable disease as shown by ELISA, indicating that the STING level in serum positively correlates with the sensitivity of NPC patients to chemoradiotherapy.